NetApp Accelerates VMware Migrations with Amazon Elastic VMware Service Integration
6.8.2025 14:00:00 CEST | Business Wire | Press Release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Amazon FSx for NetApp ONTAP® is now a supported external storage option for Amazon Elastic VMware Service (Amazon EVS) on Amazon Web Services (AWS). Amazon EVS, now generally available, is a new AWS service that allows users to run VMware Cloud Foundation (VCF) directly within their Amazon Virtual Private Cloud (Amazon VPC), alongside other applications. With Amazon EVS, organizations can quickly migrate VMware workloads to AWS to seamlessly extend and expand their VMware environments and unlock business agility and transformation.
This integration with Amazon EVS combines NetApp's proven, secure data management and protection capabilities with AWS's scale, resilience, and performance, allowing customers to simplify and accelerate their AWS migration without re-platforming or re-factoring their existing applications or changing their data management workflows.
Migrating mission critical workloads to the cloud can help businesses drive transformation by eliminating aging infrastructure, reducing operational costs, and meeting critical business timelines, but they need an effective data strategy to avoid introducing new challenges such as unexpected costs, sprawling IT environments, and fragmented services. As the only enterprise storage solution provider with a first-party data storage service natively built on AWS, NetApp is uniquely equipped to help customers accelerate modern workloads in the cloud by offering enterprise storage solutions natively built on AWS. Customers have been able to reduce costs by 50 percent after adopting Amazon FSx for NetApp ONTAP®. Using FSx for ONTAP to migrate and manage their VMware environments enables customers to leverage Intelligent Data Infrastructure to improve migration planning and decrease total cost of ownership with built-in data management capabilities.
“Customers utilizing Amazon EVS with FSx for ONTAP can now enjoy the same data efficiency, protection, and automation they trust on-premises,” said Pravjit Tiwana, Senior Vice President and General Manager, Cloud Storage at NetApp. “Through our collaboration with AWS, we’re making it easier to move critical workloads to the cloud and manage them at scale.”
To better support customers as they manage advanced workloads in the cloud, NetApp has released capabilities including:
- Amazon FSx for NetApp ONTAP support for Amazon EVS: Amazon EVS, the new self-managed cloud solution for VMware from AWS, is now generally available, and FSx for NetApp ONTAP is a supported storage option. Amazon EVS automates and simplifies deployments and provides a ready-to-use VCF environment on AWS. This allows VMware administrators to quickly migrate VMware-based virtual machines to AWS using the same VCF software and tools they already use in their on-premises environment. Using FSx for ONTAP as external storage for the Amazon EVS environment reduces overhead by providing advanced data management and protection functionality, reducing total cost of ownership and increasing cyber resiliency.
- Migration advisor for Amazon EVS workloads: The migration advisor feature of BlueXP workload factory for AWS now supports Amazon EVS workloads, helping simplify and speed up migration processes. Customers can now automate the discovery of on-premises virtual machines, provisioning of FSx for ONTAP, and placement of datastores in Amazon EVS.
- Expanded VMware disaster recovery support in BlueXP: BlueXP disaster recovery for VMware now integrates with Amazon EVS, leveraging FSx for ONTAP storage as a reliable disaster recovery target. Supported datastore options include NFS (file-based) and VMFS (block-based) via the iSCSI protocol, ensuring versatile and efficient disaster recovery solutions.
- Enhanced ransomware protection features: Further enabling customers to protect Amazon EVS workloads, NetApp ONTAP autonomous ransomware protection (ARP) for FSx for ONTAP is used to detect and respond to ransomware events in real time. Additionally, NetApp BlueXP ransomware protection service supports FSx for ONTAP to help customers with comprehensive orchestration of their defense against ransomware events. Enabling these features to support workloads natively in AWS helps protect customer data and minimize downtime by proactively detecting ransomware at the storage layer across the hybrid cloud.
Xtravirt, a NetApp Preferred Partner and an AWS partner, believes these latest announcements will come as good news to businesses looking to migrate VMware workloads to public cloud. “Enabling support for FSx for ONTAP on Amazon EVS gives customers more granular control over the data powering some of their most important workloads,” said Robin Gardner, CCO at Xtravirt. “Customers will be able access NetApp’s advanced data management functionality to reduce the overhead of managing virtual environments and more efficiently and securely manage hybrid deployments.”
No ransomware detection or prevention system can completely guarantee safety from a ransomware attack. Although it’s possible that an attack might go undetected, NetApp technology acts as an important additional layer of defense.
Additional Resources
- Amazon Elastic VMware Service Announces Support for Amazon FSx for NetApp ONTAP
- Industry-Leading Security No Matter Where Your Data Lives
- Amazon FSx for NetApp ONTAP
- BlueXP workload factory
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data, operational and workload services to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our operational and workload services provide continuous optimization of performance and efficiency for infrastructure and workloads through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250806245890/en/
Contacts
Media Contact:
Kenya Hayes
NetApp
kenya.hayes@netapp.com
Investor Contact:
Kris Newton
NetApp
kris.newton@netapp.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom